Nursing 2025-2026 drug handbook.

Material type: TextTextPublication details: Philadelphia : Wolters Kluwer, 2025.Edition: Forty fifth edition ; Philippine editionDescription: xi, 1668 pages; 21 cmContent type:
  • text
Media type:
  • unmediated
Carrier type:
  • volume
ISBN:
  • 9781975217129
Subject(s): LOC classification:
  • 615.1 N9381 2025
Summary: The #1 Drug Guide for nurses and clinicians... always dependable, always up to-date! Now in its 45th Edition, Nursing 2025-2026 Drug Handbook delivers the most current nursing focused information on more than 3,600 generic, brand-name, and combination drugs in an easy-to-use A-Z format. Features: NEW! Includes 24 brand-new FDA-approved drugs -- tabbed and conveniently grouped in a handy "NEW DRUGS" section for easy retrieval ; NEW! Thousands of clinical updates -- new dosages and indications, FDA boxed warnings, genetic-related information, adverse reactions, interactions, nursing considerations, clinical alerts, and patient teaching information ; Special focus on U.S. and Canadian drug safety issues and concerns.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Call number Status Barcode
Books Books FEU - Cavite Higher Education HED Library REF 615.1 N9381 2025 (Browse shelf(Opens below)) Available HED6887

Includes index

in English

The #1 Drug Guide for nurses and clinicians... always dependable, always up to-date! Now in its 45th Edition, Nursing 2025-2026 Drug Handbook delivers the most current nursing focused information on more than 3,600 generic, brand-name, and combination drugs in an easy-to-use A-Z format. Features: NEW! Includes 24 brand-new FDA-approved drugs -- tabbed and conveniently grouped in a handy "NEW DRUGS" section for easy retrieval ; NEW! Thousands of clinical updates -- new dosages and indications, FDA boxed warnings, genetic-related information, adverse reactions, interactions, nursing considerations, clinical alerts, and patient teaching information ; Special focus on U.S. and Canadian drug safety issues and concerns.

0

There are no comments on this title.

to post a comment.